| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advancing Clinical Trial Design in Pulmonary Hypertension
|
Grieve, Andy P.
|
|
2013
|
3 |
1 |
p. 217-225
|
article
|
| 2 |
Anticipated Classes of New Medications and Molecular Targets for Pulmonary Arterial Hypertension
|
Morrell, Nicholas W.
|
|
2013
|
3 |
1 |
p. 226-244
|
article
|
| 3 |
Appendix
|
|
|
2013
|
3 |
1 |
p. 267-268
|
article
|
| 4 |
Author's Reply
|
Trip, Pia
|
|
2013
|
3 |
1 |
p. 122
|
article
|
| 5 |
Author's Reply
|
Cork, David P.
|
|
2013
|
3 |
1 |
p. 123-124
|
article
|
| 6 |
Clinical Trials in Neonates and Children: Report of the Pulmonary Hypertension Academic Research Consortium Pediatric Advisory Committee
|
Adatia, Ian
|
|
2013
|
3 |
1 |
p. 252-266
|
article
|
| 7 |
Clinical Trials in Pulmonary Hypertension: Time for a Consortium
|
Newman, John H.
|
|
2013
|
3 |
1 |
p. 245-251
|
article
|
| 8 |
Combining Induced Pluripotent Stem Cell with Next Generation Sequencing Technology to Gain New Insights into Pathobiology and Treatment of Pulmonary Arterial Hypertension
|
Rabinovitch, Marlene
|
|
2013
|
3 |
1 |
p. 153-155
|
article
|
| 9 |
Comparison of Acute Hemodynamic Effects of Inhaled Nitric Oxide and Inhaled Epoprostenol in Patients with Pulmonary Hypertension
|
Preston, Ioana R.
|
|
2013
|
3 |
1 |
p. 68-73
|
article
|
| 10 |
Developing Treatments for Pulmonary Arterial Hypertension
|
Wilkins, Martin R.
|
|
2013
|
3 |
1 |
p. 156-159
|
article
|
| 11 |
Development of the Pulmonary Vasculature: Current Understanding and Concepts for the Future
|
Peng, Tien
|
|
2013
|
3 |
1 |
p. 176-178
|
article
|
| 12 |
Differences between Basal Lung Levels of Select Eicosanoids in Rat and Mouse
|
Sagliani, Kristen D.
|
|
2013
|
3 |
1 |
p. 82-88
|
article
|
| 13 |
Dysfunctional Resident Lung Mesenchymal Stem Cells Contribute to Pulmonary Microvascular Remodeling
|
Chow, Kelsey
|
|
2013
|
3 |
1 |
p. 31-49
|
article
|
| 14 |
Human Immunodeficiency Virus, Herpes Virus Infections, and Pulmonary Vascular Disease
|
Flores, Sonia C.
|
|
2013
|
3 |
1 |
p. 165-170
|
article
|
| 15 |
Human Immunodeficiency Virus-1 Transgene Expression Increases Pulmonary Vascular Resistance and Exacerbates Hypoxia-Induced Pulmonary Hypertension Development
|
Porter, Kristi M.
|
|
2013
|
3 |
1 |
p. 58-67
|
article
|
| 16 |
Integrating Molecular Genetics and Systems Approaches to Pulmonary Vascular Diseases
|
Geraci, Mark W.
|
|
2013
|
3 |
1 |
p. 171-175
|
article
|
| 17 |
Mechanical Forces Stimulate Endothelial Microparticle Generation via Caspase-Dependent Apoptosis-Independent Mechanism
|
Vion, Anne Clémence
|
|
2013
|
3 |
1 |
p. 95-99
|
article
|
| 18 |
Mechanics and Mechanisms of Pulmonary Hypertension: An Introduction to the 55th Annual Thomas L. Petty Aspen Lung Conference
|
Bull, Todd M.
|
|
2013
|
3 |
1 |
p. 127
|
article
|
| 19 |
Mechanics and Mechanisms of Pulmonary Hypertension — Conference Summary and Translational Perspectives
|
Seeger, Werner
|
|
2013
|
3 |
1 |
p. 128-136
|
article
|
| 20 |
Mechanisms of Development of Chronic Obstructive Pulmonary Disease-Associated Pulmonary Hypertension
|
Barberà, Joan Albert
|
|
2013
|
3 |
1 |
p. 160-164
|
article
|
| 21 |
Mechanisms of Right Heart Failure—A Work in Progress and a Plea for Failure Prevention
|
Voelkel, Norbert F.
|
|
2013
|
3 |
1 |
p. 137-143
|
article
|
| 22 |
Metabolism and Bioenergetics in the Right Ventricle and Pulmonary Vasculature in Pulmonary Hypertension
|
Archer, Stephen L.
|
|
2013
|
3 |
1 |
p. 144-152
|
article
|
| 23 |
Nitric Oxide Deficiency in Pulmonary Hypertension: Pathobiology and Implications for Therapy
|
Tonelli, Adriano R.
|
|
2013
|
3 |
1 |
p. 20-30
|
article
|
| 24 |
Phospholipase D Signaling Mediates Reactive Oxygen Species-Induced Lung Endothelial Barrier Dysfunction
|
Usatyuk, Peter V.
|
|
2013
|
3 |
1 |
p. 108-115
|
article
|
| 25 |
Pim-1: A New Biomarker in Pulmonary Arterial Hypertension
|
Renard, Sébastien
|
|
2013
|
3 |
1 |
p. 74-81
|
article
|
| 26 |
Pulmonary Heart Disease: The Heart-Lung Interaction and its Impact on Patient Phenotypes
|
Forfia, Paul R.
|
|
2013
|
3 |
1 |
p. 5-19
|
article
|
| 27 |
Rare Etiological Causes of Takotsubo Cardiomyopathy
|
Kapoor, Shailendra
|
|
2013
|
3 |
1 |
p. 122-123
|
article
|
| 28 |
Readership: The Heart of Pulmonary Circulation
|
Yuan, Jason X.J.
|
|
2013
|
3 |
1 |
p. 1-2
|
article
|
| 29 |
Should Cardiopulmonary Exercise Testing Become a Part of Regular Evaluation for Patients with a Family History of Pulmonary Hypertension?
|
Babu, Abraham Samuel
|
|
2013
|
3 |
1 |
p. 121-122
|
article
|
| 30 |
Spread the Word, Children are Still not “Small Adults”
|
Fike, Candice D.
|
|
2013
|
3 |
1 |
p. 3-4
|
article
|
| 31 |
Supplementation of Iron in Pulmonary Hypertension: Rationale and Design of a Phase II Clinical Trial in Idiopathic Pulmonary Arterial Hypertension
|
Howard, Luke S.G.E.
|
|
2013
|
3 |
1 |
p. 100-107
|
article
|
| 32 |
The Pulmonary Hypertension Academic Research Consortium
|
Rich, Stuart
|
|
2013
|
3 |
1 |
p. 203-205
|
article
|
| 33 |
Thomas L. Petty Aspen Lung Conference 55th Annual Meeting
|
|
|
2013
|
3 |
1 |
p. 179-200
|
article
|
| 34 |
Time from Symptoms to Definitive Diagnosis of Idiopathic Pulmonary Arterial Hypertension: The Delay Study
|
Strange, Geoff
|
|
2013
|
3 |
1 |
p. 89-94
|
article
|
| 35 |
Transitioning from Parenteral Treprostinil to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
|
Raina, Amresh
|
|
2013
|
3 |
1 |
p. 116-120
|
article
|
| 36 |
Updating Clinical Endpoint Definitions
|
Hassoun, Paul M.
|
|
2013
|
3 |
1 |
p. 206-216
|
article
|
| 37 |
Vascular Histomolecular Analysis by Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension
|
Rothman, Abraham
|
|
2013
|
3 |
1 |
p. 50-57
|
article
|
Journal description